Guarded Prognosis just released in eBook format – click here for Amazon or Barnes & Noble.

Click Here for Dr. Lockshin’s Current Comments

From the Hospital for Special Surgery’s Discovery to Recovery| Fall 2007: Focused on Women’s Health

Rheumatologist Michael D. Lockshin, MD, has spent over 25 years studying clinical aspects of rheumatic disease and pregnancy. Dr. Lockshin is the director of the Barbara Volcker Center for Women and Rheumatic Disease and co-director of the Mary Kirkland Center for Lupus Research, as well as a professor of medicine and obstetrics-gynecology at Weill Cornell Medical College. He is currently working with Jane E. Salmon, MD, on PROMISSE – a multimillion dollar, multicenter study funded by the National Institutes of Health that seeks to define biomarkers that predict a compromised pregnancy outcome in patients with lupus. “The PROMISSE study is the type of research that will lead to a new textbook that will rewrite the rules about lupus pregnancy,” said Dr. Lockshin, seen here with Brendan Feldgoise, one of the first babies delivered by a mother with lupus in this study.